Desperate people can make $30 donating plasma, up to 104 times a year, in this $20 billion industry

Quick Read

At the Recode conference in Rancho Palos Verdes, California, Jesse Karmazin, who leads the small biotech startup Ambrosia, told New Scientist that he had positive results from a preliminary trial injecting older patients with younger plasma,the liquid part of blood that doesn’t contain any cells

Quick Read

Community consultation is the only way to study issues in emergency medicine. “If you require consent for all clinical studies you end up getting into a Catch-22 where you can never systematically learn about anything in an emergency setting,” said Nancy Kass, deputy director of the Johns Hopkins Berman Institute of Bioethics. “A person having a heart attack cannot give consent.”

Quick Read